Skip to content

Fusobacterium Nucleatum at Colorectal Cancer Sites

Presence of Fusobacterium Nucleatum at Colorectal Cancer Sites - Influencing Factors and Screening Possibilities

Status
UNKNOWN
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT05945082
Enrollment
150
Registered
2023-07-14
Start date
2017-11-29
Completion date
2025-12-31
Last updated
2023-07-14

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Colorectal Cancer, Periodontitis

Brief summary

Recent studies suggest an association of periodontitis with an overall increased cancer risk but also with cancer development in specific anatomic regions, such as in the colon. The gut microbiome in general and specifically Fusobacterium nucleatum have been described to likely affect colorectal cancer (CRC) development. The present project intends to evaluate the possible contribution of the oral cavity as a reservoir for dissemination of F.nucleatum to the colon. Additionally, the gut microbiome and dietary intake will be assessed as possible factors influencing colonization of CRC sites with F. nucleatum and an association of F.nucleatum colonization in the colon with parameters in the saliva and serum will be tested. One-hundred-fifty patients diagnosed with CRC will be included; after cancer diagnosis and before starting cancer treatment a periodontal examination will be done and saliva and serum samples and at the time-point of tumor resection a biopsy of the CRC sites will be collected.

Interventions

OTHERbiopsy

biopsy of a colorectal cancer site

Sponsors

Skane University Hospital
CollaboratorOTHER
Malmö University
Lead SponsorOTHER

Study design

Allocation
NA
Intervention model
SINGLE_GROUP
Primary purpose
SCREENING
Masking
NONE

Eligibility

Sex/Gender
ALL
Age
18 Years to 120 Years
Healthy volunteers
No

Inclusion criteria

* diagnosis of colorectal cancer

Design outcomes

Primary

MeasureTime frameDescription
Presence of F.nucleatum in a colon cancer biopsyAt timepoint of biopsydichotomous (present / absent)

Countries

Sweden

Contacts

Primary ContactKristina Bertl
kristina.bertl@mau.se00436645151194
Backup ContactAndreas Stavropoulos
andreas.stavropoulos@mau.se

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 5, 2026